Trainee Death Simulator

Bone Nail · 2024 · $5.99 · Indie · deal grade D

Measured on 2026-10-05 03:58 UTC. The whole catalog is re-measured daily; a game that just launched can move fast between passes.

Estimated net residual revenue: $290 to $435 per month
Opportunity: $362 per month at x1.00 dormancy
Estimated lifetime owners: 70.4k
93% positive across 2020 reviews · 8.3 reviews/month

Why it's flagged

Developer active, last post 0 months ago
Studio active elsewhere (4 titles tracked), so this one may welcome a partner
Store page localized in only 4 language(s)
Last discounted 0 months ago, 6 sales in the last 12 months

Analyst notes (AI-assisted)

Note written 2026-09-15; the live figures above take precedence over any numbers in it.

A 2024 indie roguelike deck-builder where players simulate training cycles with permadeath mechanics, cute visuals, and a gambling-card core loop.

Trainee Death Simulator has quietly built a 93% positive rating on modest but stable residuals. The game's high achievement completion rate (96.5%) and strong sentiment in Chinese and Japanese markets suggest an engaged, niche audience that tolerates repetitive design. For a small publisher or revival-minded studio, the low player count (4 concurrent) and dormant dev activity (no posts in 20 months) point to an under-marketed gem with room for content drops, regional localization polish, or porting to mobile or console. Not a blockbuster play, but a solid four-figure monthly residual with upside if community needs are met. Most realistic play: revival.

Risk: Roguelike deck-builders are crowded; Trainee Death Simulator lacks franchise recognition or mainstream visibility despite high-quality sentiment.
Risk: Repetitive round resets and autoclicker reliance suggest core loop friction that may cap ceiling without redesign or new content.
Risk: Developer has posted zero updates in 20 months; revival would require external team commitment to avoid perception of abandonment.

This case as Markdown · Estimates carry ±30-50% error per title.